Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a high burden of comorbidities and anatomical complexity. In this context, the term complex PCI has been introduced over the past decade to identify a broad spectrum of interventions with complex anatomical features, such as severe calcification, chronic total occlusion, bifurcation lesions, or multivessel treatment. 

Resultado a 3 años luego de ATC con técnica de 2- stents vs Provisional stent por bifurcaciones complejasTo date, limited data have been published on the association between complex PCI and the risk of adverse events, and it remains unclear whether complex PCI is independently associated with a higher risk of ischemic and bleeding events.

The aim of this study was to perform a systematic review and a Bayesian meta-analysis to evaluate the association between complex PCI and the risk of ischemic and bleeding events.

The Primary Endpoint (PE) was the rate of myocardial infarction (MI) and major bleeding. Secondary Endpoints (SE) included all-cause mortality, stent thrombosis, cardiovascular death, target vessel or target lesion revascularization, and stroke.

A total of 290,039 patients were included, of whom 33% underwent complex PCI. Compared with non-complex PCI, patients undergoing complex PCI had a higher risk of myocardial infarction (HR 1.71; 95% CI: 1.49–1.96), major bleeding (HR 1.24; 95% CI: 1.14–1.35), all-cause mortality (HR 1.21; 95% CI: 1.12–1.32), cardiovascular death (HR 1.29; 95% CI: 1.15–1.46), stent thrombosis (HR 1.76; 95% CI: 1.49–2.14), target lesion or target vessel revascularization (HR 1.99; 95% CI: 1.58–2.50), and stroke (HR 1.21; 95% CI: 1.03–1.42).

Read also: Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta.

Conclusion: Significant increase in major bleeding and mortality in patients undergoing complex PCI

In conclusion, our systematic review and meta-analysis found that complex PCI is associated with a higher risk of ischemic events, including myocardial infarction, stent thrombosis, and target lesion or target vessel revascularization, compared with non-complex PCI. Additionally, complex PCI was associated with a higher risk of major bleeding. These findings highlight the increased risk associated with complex PCI in terms of both ischemic and bleeding complications.

Original Title: Ischaemic and bleeding events after complex versus non-complex PCI: a systematic review and meta-analysis.

Reference: Raffaele Piccolo et al. EuroIntervention 2026;22:e402-e414.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....